Drug Repositioning – Benefits and Challenges for Lifecycle Management

Drug repositioning, also known as drug repurposing, has significant potential to bring new therapeutics to market at lower cost, via shorter drug development timelines thereby delivering benefit for pharmaceutical companies, healthcare practitioners (HCPs) and patients. An increasingly well-used tool for Life Cycle Management, drug repositioning affords opportunities for IP creation, access to faster, less complex regulatory pathways and increased market share.

Reformulation as a nasal drug product is an increasingly popular and established strategy that can empower patients and reduce reliance on HCPs. Nasal drug delivery offers a pathway for systemic circulation and has proven highly effective for emergency administration, as evidenced by the reformulation of naloxone for the treatment of opioid overdose. However, the nasal delivery route can be challenging with multiple scientific and regulatory hurdles to overcome. Dose levels, dose regimens and therapeutic efficacy in new patient populations are just a few of the issues to be considered.

Watch this webinar to learn more about drug repositioning via reformulation as a nasal drug product.  Learn about the nasal spray devices we offer and how our experts can help to accelerate formulation – powder or liquid – to a successful conclusion. Case studies illustrate what can be achieved. Whatever stage of development you’re at Aptar Pharma can help you to reformulate for nasal delivery and breathe new life into mature drug products.